Press "Enter" to skip to content

New patent expiration for APIL drug FEMCON FE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug FEMCON FE

Annual Drug Patent Expirations for FEMCON+FE
Annual Drug Patent Expirations for FEMCON+FE

Femcon Fe is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

Drug patent litigation for FEMCON FE.

The generic ingredient in FEMCON FE is ethinyl estradiol; norethindrone. Two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug FEMCON FE
Do NOT follow this link or you will be banned from the site!